Xcel Brands, Inc. Announces Licensing Deal With The Madame

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
Xcel Brands, Inc. Announces Licensing Deal With The Madame Alexander Doll Company


Xcel Brands, Inc. (OTCQB:XELB) has signed an exclusive licensing agreement with The Alexander Doll Company to create a selection of Madame Alexander dolls, doll apparel and doll accessories under the Isaac Mizrahi New York label. It will consist of both collectible and play dolls: Cissy™, the iconic 21" couture collectible doll, a 16" contemporary fashion collectible doll, and an 18" play doll. The collection will debut at the International Toy Fair in New York City in February 2014. The dolls will be sold through specialty and department stores as well as select websites including www.madamealexander.com.
Robert D'Loren, Chairman and Chief Executive Officer, Xcel Brands, Inc. said, "We are very excited to partner with Madame Alexander on this wonderful and smart collection of designer, limited edition and play dolls.  This is an important partnership for us as we continue to grow our children's business."

Isaac Mizrahi, Creative Director, Xcel Brands, Inc. said, "Working with Madam Alexander is a dream for me. They have always represented the highest quality and most beautiful dolls in the world and the opportunity to work with them is a total honor."

Gale Jarvis, President of The Madame Alexander Doll Company, said, "We are thrilled to have the opportunity to partner with Xcel Brands & Isaac Mizrahi. The Madame Alexander Company, celebrating its 90th anniversary this year, has worked with many of the top fashion designers designing dolls and doll size outfits for over four generations, and we are honored to collaborate with Isaac, one of the most successful American designers today. We look forward to delighting doll lovers, both young girls with the new 18" doll fashion collection and our avid doll collector fans with Isaac's iconic fashions. Madame Alexander and Isaac together are bringing distinctive fashion and design to the world of doll play for girls of all ages."

Xcel Brands, Inc. engages in the acquisition, design, licensing and marketing of consumer brands incorporating an OMNICHANNEL sales strategy inclusive of interactive media, digital and bricks and mortar retail.  In 2011, the company acquired designer apparel brand Isaac Mizrahi New York and an interest in Liz Claiborne New York, quickly expanding into 100+ categories for the Isaac Mizrahi brand.  The company's executive management team possesses significant talent, experience and a proven track record of success to create and grow branded consumer products businesses.  www.xcelbrands.com

Isaac Mizrahi has been a leader in the fashion industry for almost 30 years.  Since his first collection in 1987, Mr. Mizrahi's designs have come to stand for timeless, cosmopolitan style.  He has been awarded four CFDA awards, including a special award in 1996 for the groundbreaking documentary "Unzipped." Recently, Mr. Mizrahi launched the Isaac Mizrahi New York and Isaac Mizrahi Jeans collections, available at better retailers.  Previously, in December 2009, Mr. Mizrahi launched his exclusive lifestyle collection, ISAACMIZRAHILIVE! on QVC. In addition, television audiences have come to value Isaac's media presence through his roles on "Project Runway All Stars" for Lifetime, "The Fashion Show" for Bravo and his own series for both Oxygen and the Style Network.  www.isaacmizrahi.com

Alexander Doll Company was founded in 1923 by Beatrice Alexander and is now owned by Kahn Lucas Lancaster, Inc. The company designs, manufactures and sells a wide range of dolls - collectible, fashion, baby and play, as well as related accessories. In addition to their own brands, Madame Alexander™ and Newborn Nursery™, the company holds numerous licenses including, but not limited to Disney®, Wizard of Oz™, Gone with the Wind™, Fancy Nancy™, Pinkalicious™, Angelina Ballerina™, Pan Am and American Ballet Theatre™.  Through the years, Alexander Doll has been responsible for numerous doll industry "firsts" that have defined the company as pioneer of style and quality as well as shaped the doll world.  In 2012, intellectual property and select assets of Alexander Doll were acquired by Kahn Lucas. www.madamealexander.com

CONTACT: Judy Herbst
Senior Director, Marketing
Madame Alexander
Judyh@alexdoll.com

Erika Stair
Vice President of Public Relations
Xcel Brands, Inc.
347-727-2476
Estair@xcelbrands.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 1

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 12

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
Fosun Pharma Hits the Buyback Button: What's Next?

Updated Category News Views 0

Fosun Pharma's Bold Move Well, if this isn't Fosun Pharma making some noise! Announcing an H-share repurchase plan worth up to HK$1 billion is like setting off fireworks amidst any investor's evening. They're hollering to the market, 'We see value, and we're doubling down on it.' Crunching the Numbers In the first half of 2026, Fosun Pharma's numbers weren't just a flash...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 3

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading

Top 5 Most Recently Viewed Articles

Prologis Earnings Report: Investors' Key Insights and Analysis

Updated Category News Views 138

Understanding Prologis's Upcoming Quarterly Earnings Prologis (NYSE: PLD) is set to release its latest quarterly earnings report, and investors are eagerly awaiting the insights it will provide. As the company approaches its earnings announcement, analysts project an earnings per share (EPS) of $1.02, which serves as a benchmark for performance expectations. Investor...

Continue Reading
How Changing U.S. Jobs Report Affects Market Dynamics

Updated Category News Views 171

The recent U. S. employment report sent shockwaves through financial markets, reshaping how traders and investors eyed their portfolios. Stronger-than-expected job creation—with figures soaring over 100,000—meant one thing: the narrative on interest rates was about to change. Gone were the days of comfortably betting on rate cuts; now, everyone’s scrambling to...

Continue Reading
Suno Boosts Innovation for Creators by Acquiring WavTool

Updated Category News Views 157

Suno Boosts Innovation for Creators by Acquiring WavTool Suno has recently made a significant move in the music industry with their acquisition of WavTool. This strategic decision aims to enhance their offerings for songwriters and producers, enabling them to create music that resonates with a broader audience. By integrating WavTool's advanced capabilities into their...

Continue Reading
Leqembi's New IV Treatment Approval: A Milestone for Alzheimer’s Care

Updated Category News Views 274

Leqembi Approved for IV Maintenance Treatment BioArctic AB, a notable player in the biopharmaceutical sector, has made significant headlines with the approval of Leqembi (lecanemab) for intravenous (IV) maintenance treatment for Alzheimer’s disease in the United Kingdom. This groundbreaking decision was announced following rigorous evaluations by the Medicines and...

Continue Reading
Investors of ATYR, MLTX, BAX, and JHX Have Legal Options

Updated Category News Views 145

Overview of Class Action Lawsuits for ATYR, MLTX, BAX, JHX Attention investors! If you’ve invested in aTyr Pharma Inc. (NASDAQ: ATYR), MoonLake Immunotherapeutics (NASDAQ: MLTX), Baxter International, Inc. (NYSE: BAX), or James Hardie Industries plc (NYSE: JHX), it’s important to be aware of significant class action lawsuits affecting your investments. These companies...

Continue Reading